Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SCOPOLAMINE HYDROBROMIDE Cause Hypersensitivity? 84 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Hypersensitivity have been filed in association with SCOPOLAMINE HYDROBROMIDE. This represents 28.2% of all adverse event reports for SCOPOLAMINE HYDROBROMIDE.

84
Reports of Hypersensitivity with SCOPOLAMINE HYDROBROMIDE
28.2%
of all SCOPOLAMINE HYDROBROMIDE reports
0
Deaths
10
Hospitalizations

How Dangerous Is Hypersensitivity From SCOPOLAMINE HYDROBROMIDE?

Of the 84 reports, 10 (11.9%) required hospitalization.

Is Hypersensitivity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SCOPOLAMINE HYDROBROMIDE. However, 84 reports have been filed with the FAERS database.

What Other Side Effects Does SCOPOLAMINE HYDROBROMIDE Cause?

Off label use (89) Headache (84) Angioedema (83) Drug intolerance (82) Dysphonia (81) Swelling face (81) Swollen tongue (81) Drug ineffective for unapproved indication (70) Drug ineffective (42) Product use in unapproved indication (33)

What Other Drugs Cause Hypersensitivity?

ETANERCEPT (10,846) ADALIMUMAB (10,641) METHOTREXATE (9,799) TOCILIZUMAB (9,076) ABATACEPT (8,945) INFLIXIMAB (8,519) RITUXIMAB (8,408) ADAPALENE (8,356) LEFLUNOMIDE (7,926) CERTOLIZUMAB PEGOL (7,353)

Which SCOPOLAMINE HYDROBROMIDE Alternatives Have Lower Hypersensitivity Risk?

SCOPOLAMINE HYDROBROMIDE vs SEBELIPASE ALFA SCOPOLAMINE HYDROBROMIDE vs SECNIDAZOLE SCOPOLAMINE HYDROBROMIDE vs SECUKINUMAB SCOPOLAMINE HYDROBROMIDE vs SELADELPAR LYSINE SCOPOLAMINE HYDROBROMIDE vs SELEGILINE

Related Pages

SCOPOLAMINE HYDROBROMIDE Full Profile All Hypersensitivity Reports All Drugs Causing Hypersensitivity SCOPOLAMINE HYDROBROMIDE Demographics